TABLE 2.
Diseases and patients’ presentation scenarios for which VC was valued.
| Digital user (n = 77) |
Digital non-user (n = 128) |
|||
| First presentation % (n) |
Follow-up presentation % (n) |
First presentation % (n) |
Follow-up presentation % (n) | |
| Osteoarthritis | 9.1 (7) | 48.1 (37) | 4.7 (6) | 17.2 (22) |
| Axial spondyloarthritis | 7.8 (6) | 57.1 (44) | 1.6 (2) | 22.7 (29) |
| Fibromyalgia | 9.1 (7) | 44.2 (34) | 7.0 (9) | 18.8 (24) |
| Juvenile idiopathic arthritis | 3.9 (3) | 44.2 (34) | 1.6 (2) | 16.4 (21) |
| Connective tissue diseases | 3.9 (3) | 42.9 (33) | 0.8 (1) | 16.4 (21) |
| Crystal arthropathies | 5.2 (4) | 46.7 (36) | 1.6 (2) | 18.8 (24) |
| Osteoporosis | 10.4 (8) | 40.3 (31) | 4.7 (6) | 19.5 (25) |
| Psoriatic arthritis | 5.2 (4) | 57.1 (44) | 1.6 (2) | 21.9 (28) |
| Rheumatoid arthritis | 6.5 (5) | 59.7 (46) | 2.3 (3) | 21.9 (28) |
| Vasculitides | 3.9 (3) | 32.5 (25) | 1.6 (2) | 16.4 (21) |